Published in Bone Marrow Transplant on June 30, 2008
Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science (2000) 10.81
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology (2008) 8.10
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice. Ann Oncol (2011) 3.55
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34
Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 3.18
Double-stranded RNA in vaccinia virus infected cells. Nature (1969) 2.83
Contribution of increasing CO2 and climate to carbon storage by ecosystems in the United States. Science (2000) 2.51
Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation. Lancet (1999) 2.26
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med (2000) 2.16
Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation (1999) 2.16
Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade. Transplantation (2002) 2.15
The specificity of interferon induction in chick embryo cells by helical RNA. Proc Natl Acad Sci U S A (1969) 2.12
Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss. Am J Transplant (2014) 2.09
Human hydatidosis in New South Wales and the Australian Capital Territory, 1987-1992. Med J Aust (1996) 2.05
The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg (2001) 2.05
Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J Clin Invest (1998) 1.99
The use of epidural analgesia in lower limb free flap harvest. Br J Oral Maxillofac Surg (2007) 1.95
High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol (1996) 1.91
Mechanism of synthesis of vaccinia virus double-stranded ribonucleic acid in vivo and in vitro. J Virol (1971) 1.87
Skin graft tolerance across a discordant xenogeneic barrier. Nat Med (1996) 1.86
Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest (2000) 1.86
Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychol Med (2003) 1.82
Nucleotide pool levels in growing, inhibited, and transformed chick fibroblast cells. Biochemistry (1970) 1.78
Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res (1995) 1.77
Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol (1999) 1.77
Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol (1994) 1.77
Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Bone Marrow Transplant (2010) 1.68
Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest (2000) 1.65
Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med (1998) 1.65
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant (2007) 1.64
Indoor air quality and acute lower respiratory infection in Indian urban slums. Environ Health Perspect (1998) 1.51
Portal biliopathy. J Gastroenterol Hepatol (2001) 1.51
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant (2014) 1.49
Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood (1994) 1.44
Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation (2001) 1.44
Patient controlled sedation during central neuraxial anesthesia. J Postgrad Med (2009) 1.43
Transplants from the same donor. Ann Intern Med (1991) 1.43
Dynamics of organic carbon and microbial biomass in alluvial soil with tillage and amendments in rice-wheat systems. Environ Monit Assess (2006) 1.42
Synthesis of human interferon beta 1 in Escherichia coli infected by a lambda phage recombinant containing a human genomic fragment. Eur J Biochem (1981) 1.41
Functional differences in Kv1.5 currents expressed in mammalian cell lines are due to the presence of endogenous Kv beta 2.1 subunits. J Biol Chem (1996) 1.40
Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant (1998) 1.39
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant (2011) 1.38
Börjeson-Forssman-Lehmann syndrome: clinical manifestations and gene localization to Xq26-27. Am J Med Genet (1989) 1.38
Early release of growth inhibition in cells infected with Rous sarcoma virus. Proc Natl Acad Sci U S A (1968) 1.38
A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer. Clin Cancer Res (2001) 1.37
Mixed chimerism and transplantation tolerance. Annu Rev Med (2001) 1.36
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant (2000) 1.33
Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today (1988) 1.33
Inducible, brain region-specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaine. Brain Res (2003) 1.31
Interferon induction and action. Annu Rev Microbiol (1971) 1.30
Comparison of interpolation and central activation ratios as measures of muscle inactivation. Muscle Nerve (2001) 1.29
Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Biol Blood Marrow Transplant (1999) 1.28
Specific binding of phosphatidylinositol 4,5-bisphosphate to calcium-dependent activator protein for secretion (CAPS), a potential phosphoinositide effector protein for regulated exocytosis. J Biol Chem (1998) 1.27
B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant (2009) 1.27
A provisional database for the silicon content of foods in the United Kingdom. Br J Nutr (2005) 1.26
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation. Bone Marrow Transplant (2007) 1.25
Cronobacter species (formerly known as Enterobacter sakazakii) in powdered infant formula: a review of our current understanding of the biology of this bacterium. J Appl Microbiol (2012) 1.25
Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation (1998) 1.25
Chromosomal breakpoints in cholangiocarcinoma cell lines. Genes Chromosomes Cancer (1990) 1.24
On the biosynthesis and structure of double-stranded RNA in vaccinia virus-infected cells. Proc Natl Acad Sci U S A (1969) 1.23
Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation (1999) 1.20
Extended rituximab therapy in Waldenström's macroglobulinemia. Ann Oncol (2005) 1.20
Results of gal-knockout porcine thymokidney xenografts. Am J Transplant (2009) 1.19
Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant (1996) 1.19
Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening. Control Clin Trials (1997) 1.18
Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation (1996) 1.18
Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood (1997) 1.18
Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation. Am J Transplant (2011) 1.17
The induction of interferon by natural and synthetic polynucleotides.hs. Prog Nucleic Acid Res Mol Biol (1971) 1.17
Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med (1998) 1.17
Inhibition of early vaccinia virus ribonucleic acid synthesis in interferon-treated chicken embryo fibroblasts. J Virol (1972) 1.16
Mixed chimerism as an approach for the induction of transplantation tolerance. Transplantation (1999) 1.16